Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA
Post by: Colleen Parr Dekker
Elanco Animal Health Announces One Health Antibiotic Stewardship Summit
Landmark thought leadership meeting to be held September 21-22 in Washington, D.C.
GREENFIELD, IND. – Last June leaders from across human and animal health gathered at the White House Forum on Antibiotic Stewardship to improve antibiotic stewardship and to protect long-term effectiveness of antibiotics. Building on the collaboration created at that event, Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), has announced a One Health Antibiotic Stewardship Summit for global industry and food chain leaders to continue building dialogue and actions that address this challenge.
The invitation-only event will be held September 21-22 in Washington, D.C. Speakers, panelists and facilitators will include leaders from the World Health Organization, the World Organization for Animal Health, World Wildlife Fund, the Gates Foundation and the Pew Charitable Trusts, as well as food company leaders and livestock producers.
Jim Collins, thought leader and best-selling author of titles such as Good to Great and Built to Last, will also provide insights on creating a long-term sustainable food chain by focusing on transformative goals. While Mark Kramer, one of the creators of the shared value concept, will bring a unique lens to help participants reframe the challenge –responsible use of antibiotics and development of viable alternatives can lead to improved social and environmental impact, but also greater business value for the food chain.
With an innovative, shared-value approach, participants can expect to be fully engaged in three afternoon working sessions to create policy and practice recommendations bringing greater clarity on One Health and Antibiotic Stewardship. Sessions include:
Veterinary Oversight and Capacity Improvement chaired by Dr. Rene Carlson, DVM & President, World Veterinary Association. Today there is a significant gap in veterinary availability and training in some developing countries, and even in parts of the United States. This session will explore ideas and recommendations to increase veterinary capacity globally.
Practices of Judicious Use, Principles and Measurement chaired by Karin Hoelzer, DVM, PhD, Officer of Health Programs, The Pew Charitable Trusts. This working group will identify fundamental principles of responsible use and appropriate and transparent metrics for measurement.
Pathways for Innovation and New Solutions for Current Needs chaired by Carel du Marchie Sarvaas, Executive Director Health for Animals. This working group will identify potential pathways to expedite approvals of new solutions that can enhance animal health and limit antimicrobial resistance development and impact.
“This is a complex issue, but it’s broader than just antibiotic resistance. It’s ultimately about One Health – human health, animal health and the health of our planet are all inextricably linked,” said Jeff Simmons, president, Elanco Animal Health. “Without all three, the entire system is compromised. Sick animals also jeopardize the safety, availability and affordability of our food, as well as expend precious natural resources. Human health requires healthy, productive animals.”
The event will also include a progress update on Elanco’s multi-faceted eight–point plan to safeguard antibiotics for future generations while protecting animal well-being. The plan is designed to address the most pressing concerns around antibiotic use in livestock around the world. Key components to this plan include increasing responsible use, reducing shared class use (those antibioitics used both in humans and animals) and replacing antibiotics with alternatives to keep animals healthy.
“Today, approximately 20 percent of livestock are lost to disease, creating unnecessary animal suffering and a significant source of food waste and resources,” Simmons said. “This is a challenging endeavor, but we believe by working collaboratively across the food chain we can make a difference, shaping a positive future with better health outcomes for people, animals and the planet.”
For more information about the event, email firstname.lastname@example.org.
Elanco provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries around the world. We value innovation, both in scientific research and daily operations, and strive to cultivate a collaborative work environment for more than 6,500 employees worldwide. Together with our customers, we are committed to raising awareness about global food security, and celebrating and supporting the human-animal bond. Founded in 1954, Elanco is a division of Eli Lilly and Company. Our worldwide headquarters and research facilities are located in Greenfield, Indiana. Visit us at Elanco.com and EnoughMovement.com.
Colleen Parr Dekker
+1 317 276 4076
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.